Literature DB >> 8247543

A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes.

S T Lee1, K M Strunk, R A Spritz.   

Abstract

We have used the reverse transcription-polymerase chain reaction to survey the repertoire of protein tyrosine kinases expressed in cultured normal human melanocytes, a differentiated cell type derived from the neural crest. We identified 25 different tyrosine kinase cDNAs among a total of 608 protein tyrosinase kinase-related cDNAs analyzed. Six encode receptor tyrosine kinases for known ligands, several of which have been implicated in controlling melanocyte proliferation in vitro. Two others encode apparent receptor tyrosine kinases for unknown ligands. Four encode known non-receptor tyrosine kinases and five encode previously identified anonymous protein tyrosine kinases. Of the eight other melanocyte-associated protein tyrosine kinases, most or all appear to be novel. These 25 protein tyrosine kinase genes exhibit distinct patterns of expression in cultured human melanocytes, human erythroleukemia cells, and a variety of normal human tissues. We mapped 16 of the corresponding protein tyrosine kinase genes to specific human chromosomes, identifying a total of 19 human genetic loci, some of which may constitute candidate genes for genetic disorders of mammalian development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8247543

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  The cytosolic domain of protein-tyrosine kinase 7 (PTK7), generated from sequential cleavage by a disintegrin and metalloprotease 17 (ADAM17) and γ-secretase, enhances cell proliferation and migration in colon cancer cells.

Authors:  Hye-Won Na; Won-Sik Shin; Andreas Ludwig; Seung-Taek Lee
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells.

Authors:  Osamu Ikeda; Yuichi Sekine; Akihiro Mizushima; Misa Nakasuji; Yuto Miyasaka; Chikako Yamamoto; Ryuta Muromoto; Asuka Nanbo; Kenji Oritani; Akihiko Yoshimura; Tadashi Matsuda
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

3.  Protein tyrosine kinase 7 has a conserved role in Wnt/β-catenin canonical signalling.

Authors:  Francesca Puppo; Virginie Thomé; Anne-Catherine Lhoumeau; Marie Cibois; Akanksha Gangar; Frédérique Lembo; Edwige Belotti; Sylvie Marchetto; Patrick Lécine; Thomas Prébet; Michael Sebbagh; Won-Sik Shin; Seung-Taek Lee; Laurent Kodjabachian; Jean-Paul Borg
Journal:  EMBO Rep       Date:  2010-12-03       Impact factor: 8.807

4.  18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.

Authors:  Orit Jacobson; Ido D Weiss; Lu Wang; Zhe Wang; Xiangyu Yang; Andrew Dewhurst; Ying Ma; Guizhi Zhu; Gang Niu; Dale O Kiesewetter; Neil Vasdev; Steven H Liang; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2015-08-27       Impact factor: 10.057

5.  Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.

Authors:  Priya S Mathur; Jessica J Gierut; Grace Guzman; Hui Xie; Rosa M Xicola; Xavier Llor; Michael I Chastkofsky; Ansu O Perekatt; Angela L Tyner
Journal:  Mol Cancer Res       Date:  2016-03-16       Impact factor: 5.852

6.  Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine.

Authors:  Andrea Haegebarth; Wenjun Bie; Ruyan Yang; Susan E Crawford; Valeri Vasioukhin; Elaine Fuchs; Angela L Tyner
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

7.  Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.

Authors:  Midan Ai; Ke Liang; Yang Lu; Songbo Qiu; Zhen Fan
Journal:  Cancer Biol Ther       Date:  2013-01-04       Impact factor: 4.742

Review 8.  Signal transducer and activator of transcription 3 regulation by novel binding partners.

Authors:  Tadashi Matsuda; Ryuta Muromoto; Yuichi Sekine; Sumihito Togi; Yuichi Kitai; Shigeyuki Kon; Kenji Oritani
Journal:  World J Biol Chem       Date:  2015-11-26

Review 9.  Targeting protein tyrosine kinase 6 in cancer.

Authors:  Milica B Gilic; Angela L Tyner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-09-18       Impact factor: 10.680

10.  The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin.

Authors:  Patrick M Brauer; Yu Zheng; Mark D Evans; Carmen Dominguez-Brauer; Donna M Peehl; Angela L Tyner
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.